News - June 18, 2020

Need for a Mutual Recognition Agreement between the EU and UK

EUCOPE, together with other European pharmaceutical trade associations, wrote a letter to the presidents of the Commission, Council and Parliament, as well as Trade Commissioner Phil Hogan and the EU’s chief negotiator Michel Barnier, voicing our shared concern about the lack of progress within the negotiations between the UK and the EU with only 6 months until the end of the Transition period for additional arrangements.

For the life science sector, irrespective of our readiness, [a failure to reach an agreement] will, in the short-term, introduce disruptions to medicine supply chains causing delays in access to medicines for both EU and UK patients and, in the long term, reduce the competitiveness of the EU and UK life science hubs vis-à-vis the US, Japan and China“, emphasise the signatories.

The letter can be downloaded here.